These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9269662)

  • 21. Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF).
    Stanworth SJ; Bhavnani M; Chattopadhya C; Miller H; Swinson DR
    QJM; 1998 Jan; 91(1):49-56. PubMed ID: 9519212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Lübbe AS; Schwella N; Riess H; Huhn D
    Blut; 1990 Dec; 61(6):379-80. PubMed ID: 2291988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome.
    Markusse HM; Breedveld FC; Fibbe WE
    Arthritis Rheum; 1990 Dec; 33(12):1865-7. PubMed ID: 2261008
    [No Abstract]   [Full Text] [Related]  

  • 24. Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus.
    Hellmich B; Csernok E; de Haas M; von dem Borne AE; Schatz H; Gross WL; Schnabel A
    Am J Med; 2002 Aug; 113(2):134-9. PubMed ID: 12133752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome.
    Farhey YD; Herman JH
    J Rheumatol; 1995 Jun; 22(6):1179-82. PubMed ID: 7545756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Felty's syndrome: effects of splenectomy upon granulocyte count and granulocyte-associated IgG.
    Blumfelder TM; Logue GL; Shimm DS
    Ann Intern Med; 1981 May; 94(5):623-8. PubMed ID: 7235395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome in Felty's syndrome.
    Thorne C; Urowitz MB
    Ann Rheum Dis; 1982 Oct; 41(5):486-9. PubMed ID: 7125718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release.
    Schots R; Verbruggen LA; Demanet C
    Clin Rheumatol; 1995 Jan; 14(1):116-8. PubMed ID: 7538060
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term remission of neutropenia in Felty's syndrome after a short GM-CSF treatment.
    Pereira J; Velloso ED; Loterio HA; Laurindo IM; Chamone DA
    Acta Haematol; 1994; 92(3):154-6. PubMed ID: 7871957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Felty's syndrome: retrospective study of 12 cases].
    Grosbois B; Perdriger A; Blot I; Pawlotsky Y; Leblay R
    Rev Med Interne; 1993; 14(10):1015. PubMed ID: 8009011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained response in Felty's syndrome to prolonged administration of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Moore DF; Vadhan-Raj S
    Am J Med; 1995 Jun; 98(6):591-4. PubMed ID: 7778576
    [No Abstract]   [Full Text] [Related]  

  • 32. Biological agents in the management of Felty's syndrome: a systematic review.
    Narváez J; Domingo-Domenech E; Gómez-Vaquero C; López-Vives L; Estrada P; Aparicio M; Martín-Esteve I; Nolla JM
    Semin Arthritis Rheum; 2012 Apr; 41(5):658-68. PubMed ID: 22119104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor--hematological response accompanied by pulmonary complications with lethal outcome.
    Gari-Bai AR; Rochlitz C; Riewald M; Oertel J; Huhn D
    Ann Hematol; 1992 Nov; 65(5):232-5. PubMed ID: 1457582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of neutropenia in Felty's syndrome.
    Vincent PC; Levi JA; Macqueen A
    Br J Haematol; 1974 Jul; 27(3):463-75. PubMed ID: 4416356
    [No Abstract]   [Full Text] [Related]  

  • 35. Partial splenic embolization for Felty's syndrome: a 10-year followup.
    Nakamura H; Ohishi A; Asano K; Hirose H; Hayakawa M; Iwai F; Kageyama T; Katsu M
    J Rheumatol; 1994 Oct; 21(10):1964-6. PubMed ID: 7837169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of the neutropenia of Felty's syndrome by longterm administration of recombinant granulocyte colony stimulating factor.
    Krishnaswamy G; Odem C; Chi DS; Kalbfleisch J; Baker N; Smith JK
    J Rheumatol; 1996 Apr; 23(4):763-5. PubMed ID: 8730142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felty's syndrome: favorable response to granulocyte-macrophage colony-stimulating factor in the acute phase.
    Kaiser U; Klausmann M; Kolb G; Pflüger KH; Havemann K
    Acta Haematol; 1992; 87(4):190-4. PubMed ID: 1519433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and serologic observations on 27 patients with Felty's syndrome.
    Ruderman M; Miller LM; Pinals RS
    Arthritis Rheum; 1968 Jun; 11(3):377-84. PubMed ID: 5301597
    [No Abstract]   [Full Text] [Related]  

  • 39. Sinusoidal lymphocytosis of the liver in Felty's syndrome with a review of the liver involvement in Felty's syndrome.
    Cohen ML; Manier JW; Bredfeldt JE
    J Clin Gastroenterol; 1989 Feb; 11(1):92-4. PubMed ID: 2646362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic porphyria in a case of Felty's syndrome. I. Clinical and routine biochemcial studies.
    Eales L; Sears WG; King KB; Levey MJ; Rimington C
    Clin Chem; 1972 May; 18(5):459-61. PubMed ID: 5019121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.